Recruiting studies: Transplant Related Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
NA · 1 location(s) · Medical College of Wisconsin · NCT05794880 Non-ablative Oligofractionated Radiation Therapy Before Surgical Transplantation As Radiovaccination
NA · 1 location(s) · Marc de Perrot · NCT04782752 Vitamin A and D Supplementation in Allogeneic HCT
Phase 2 · 1 location(s) · St. Petersburg State Pavlov Medical University · NCT06508099 Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT03314974 CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relap
Phase 1 · 1 location(s) · Fred Hutchinson Cancer Center · NCT04375631 Response to Influenza Vaccination in Pediatric Oncology Patients
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT05384288 Washed Microbiota Transplantation for the Treatment of Oncotherapy-Related Intestinal Complications
NA · 1 location(s) · The Second Hospital of Nanjing Medical University · NCT04721041 Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Phase 1 · 5 location(s) · Tr1X, Inc. · NCT06462365 Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Phase N/A · 8 location(s) · AIDS Malignancy Consortium · NCT05663502 A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combine
Phase 2 · 2 location(s) · Franziska Wachter · NCT05796570 A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
Phase 1 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07319364 CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Unde
Phase 2 · 3 location(s) · City of Hope Medical Center · NCT06059391 Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients
Phase 1/Phase 2 · 2 location(s) · Tata Memorial Centre · NCT07724873 Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or
Phase 2 · 6 location(s) · Orca Biosystems, Inc. · NCT07216443 Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT05318196 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Le
Phase 1/Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT03670966 Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Phase 2 · 3 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT01804634 Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback
Phase 1 · 1 location(s) · Porteus, Matthew, MD · NCT04640987 Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
Phase 2 · 1 location(s) · University of Nebraska · NCT06799195 The Organ Transplant Recipient HPV and Skin Cancer Study
Phase N/A · 3 location(s) · Merete Haedersdal · NCT05284877 Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Tra
EARLY_Phase 1 · 1 location(s) · City of Hope Medical Center · NCT06735690 Social Relationships and Accelerated Aging in Hematopoietic Cell Transplant Survivors
Phase N/A · 1 location(s) · Medical College of Wisconsin · NCT04892823 Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy
Phase N/A · 1 location(s) · Wake Forest University Health Sciences · NCT03555851 GM-CSF With Post-Transplant Cyclophosphamide
Phase 2 · 1 location(s) · Northside Hospital, Inc. · NCT04237623 BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting
Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06741072 Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymp
Phase 2 · 1 location(s) · Reem Karmali · NCT06723457 Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
Phase 2 · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT04644016

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.